Climate Change Headlines G7; Merkel Commits To Conclude TTIP During Obama’s Term 09/06/2015 by Monika Ermert for Intellectual Property Watch Leave a Comment MUNICH — The agreement of the heads of states of the United States, Canada, Japan, United Kingdom, France, Italy and Germany to reduce global warning to less than two degrees made the biggest headlines of the G7 Summit on Elmau Castle, Germany, in the Bavarian Alps. Also agreed were commitments on trade and on public health, including research and development for neglected diseases.
US Approves New Loophole In Patent Protection 08/06/2015 by Steven Seidenberg for Intellectual Property Watch Leave a Comment The US Federal Circuit Court of Appeals clearly likes patents. Over the years, the court has issued a long string of rulings that greatly strengthened the rights of patent owners. But several weeks ago, in Akamai Technologies v. Limelight Networks, the court reluctantly created a major loophole in patent protection.
Confidential USTR Emails Show Close Industry Involvement In TPP Negotiations 05/06/2015 by William New, Intellectual Property Watch 45 Comments While a full range of stakeholders would be affected by the outcome of the Trans-Pacific Partnership (TPP) agreement under secret negotiation by the United States and a dozen trading partners, corporate representatives have had a special seat at the negotiating table, as shown by hundreds of pages of confidential emails from the US Trade Representative’s office obtained by Intellectual Property Watch. The emails give a rare and fascinating perspective on how policy is developed in the trade office.
Report: Patent Activity At A High But Decline In Scientific Research Could Show Innovation Slowing 04/06/2015 by Eimear Murphy for Intellectual Property Watch 1 Comment Patent activity is currently at an all-time high, with statistics showing large growth across industry sectors in the volume of patents being filed. However, the production of scientific literature is declining, according to a new report from Thomson Reuters.
UN Review Of WSIS Intensifies; Questions About ICANN Board Role In IANA Handover 02/06/2015 by William New, Intellectual Property Watch Leave a Comment This year’s United Nations review of implementation of the 2005 World Summit on the Information Society (WSIS) is picking up pace. Meanwhile, intensive efforts continue to meet a September target for the handover from the United States of key underlying functions of the internet.
Firm Performance In Countries With & Without Open Copyright Exceptions 01/06/2015 by Intellectual Property Watch 1 Comment Mike Palmedo writes: This post presents preliminary data showing that firms in industries sensitive to copyright can succeed in countries other than the US when copyright limitations include fair use. It is an early product of an interdisciplinary project at American University, in which legal researchers are working with economics professor Walter Park to study how country’s copyright exceptions effect economic outcomes. The project has been undertaken as part of American University’s larger role coordinating the Global Network on Copyright User Rights. The research supports and expands on other recent research attempting to measure the value of fair use abroad.
European Parliament Trade Committee Tries To Defuse TTIP Controversy But Outcome Remains Uncertain 29/05/2015 by Dugie Standeford for Intellectual Property Watch 1 Comment European Commission negotiators should back away from a controversial provision in the Transatlantic Trade and Investment Partnership (TTIP) deal that would allow companies to sue governments in arbitration courts over claimed unequal treatment, the European Parliament International Trade Committee (INTA) said on 28 May. MEPs called instead for publicly appointed, independent judges, public hearings and an appellate mechanism that respects the jurisdiction of EU and national courts, the committee said.
Five Challenges Filed Against Gilead Patent Claims For Hepatitis C Drug 20/05/2015 by Intellectual Property Watch Leave a Comment Pharmaceutical company Gilead Sciences has been noted first for developing a treatment for hepatitis C, which afflicts tens of millions around the world, and then for pricing it at jaw-dropping prices ($1000 per pill) in the United States and elsewhere. Now a group of health advocates has challenged Gilead’s patent applications in five emerging economies.
Statement: Blumenthal Offers Amendment On Trade Transparency 19/05/2015 by Intellectual Property Watch Leave a Comment Senators Blumenthal, Brown, Baldwin, and Udall introduced today a trade negotiation transparency bill that would require that all formal U.S. proposals for trade agreement restrictions on domestic regulations be posted on a website. This is a common sense policy that should be broadly supported. The bill would require policies similar to the transparency policies currently followed by the European Union and by intergovernmental organizations that set similar minimum regulatory standards. But it would be a major change in the current process for trade negotiations followed by the U.S. Trade Representative, which are infamously secretive, write Sean Flynn and David Levine.
US Ponders New Trademark Rights For Racial Slurs 14/05/2015 by Steven Seidenberg for Intellectual Property Watch Leave a Comment Some words are too offensive to be registered trademarks. Racial slurs, derogatory names for ethnic groups, and other terms that disparage people can be denied registration, according to the vast majority of countries. The US, however, might soon back away from this anti-bigotry stance. The nation’s courts may be on the verge of ruling that the registration of derogatory terms is protected by the Constitution’s guarantee of free speech.